CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
July 2020—Oxford Immunotec announced the release of the research use only T-Spot Discovery SARS-CoV-2 test kit.
T-Spot Discovery SARS-CoV-2 builds on the company’s experience with tuberculosis diagnosis and the assessment of immune response to cytomegalovirus in transplant patients. The technology interrogates the immune system’s T cell response and will enable research into the measurement of the strength of that response to SARS-CoV-2. The strength of this response may be linked to protection from reinfection, the company said in a press release.
Pages: 1 2